Cellyan Biotechnology Co., Ltd

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement / Annual report / Transition report for Foreign Private Issuers

No description available

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement for securities of certain foreign private issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement / Annual report / Transition report for Foreign Private Issuers

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Correspondence with the SEC

Correspondence with the SEC

Notice of Effectiveness

Correspondence with the SEC

Registration statement for securities of certain foreign private issuers (amendment)

Letter from the SEC

Registration statement for securities of certain foreign private issuers (amendment)

Free Writing Prospectus

Registration statement for securities of certain foreign private issuers (amendment)

Correspondence with the SEC

Letter from the SEC

Registration statement for securities of certain foreign private issuers

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

CHAN Kam Leung

Wong Lap Sun

Wang Zifeng

Wu Jingyan

Liu Shu

Zhou Mike Yao

Liang Chenyu Andy